Pluristem Therapeutics Inc (NASDAQ:PSTI)

2.76
Delayed Data
As of May 06
 +0.06 / +2.22%
Today’s Change
2.32
Today|||52-Week Range
3.78
+10.40%
Year-to-Date
No recent news for Pluristem Therapeutics Inc.

Today’s Trading

Previous close2.70
Today’s open2.76
Day’s range2.72 - 2.80
Volume57,781
Average volume (3 months)135,527
Market cap$191.8M
Dividend yield--
Data as of 05/06/2015

Growth & Valuation

Earnings growth (last year)-10.53%
Earnings growth (this year)-2.38%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-44.18%
P/E ratioNM
Price/Sales418.96
Price/Book2.98

Competitors

 Today’s
change
Today’s
% change
PLXProtalix Biotherapeu...+0.03+1.42%
ENZYEnzymotec Ltd-0.04-0.44%
NDRMNeuroderm Ltd-0.45-3.69%
CRMDCorMedix Inc-0.05-0.66%
Data as of 05/06/2015

Financials

Next reporting dateJune 3, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$379.0K
Annual profit (last year)-$26.9M
Net profit margin-7,106.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Zami Aberman
President &
Chief Operating Officer
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers